Scholarlink

<p>Chondromyxoid fibroma (CMF) is a rare benign bone tumor characterized by lobulated growth, chondromyxoid stroma, and <i>GRM1</i> rearrangement. Here, we describe 3 cases of CMF with limited or no chondromyxoid stroma. The patients (2 males and 1 female) were 14–18&#xa0;years old and had lesions in the tibial diaphysis, rib, and pubic bone. The tumors measured 24–60&#xa0;mm, and were central in 2 cases and juxtacortical in 1 case. Treatment included curettage and resection, and the tumors did not recur for 2 to 8&#xa0;years after surgery. Histologically, all 3 tumors comprised sheets of uniform, non-atypical, ovoid or short spindle cells interspersed with numerous osteoclast-like giant cells. Delicate pericellular eosinophilic matrix was focally deposited in all cases, which showed chicken-wire calcification in 2 cases. Osteoid deposition in a conglomerate pattern was observed in 2 cases. Aneurysmal bone cystic changes were present in all cases. Chondromyxoid stroma was present only in ~ 10% and &lt; 5% of the tumor volume in 2 cases, whereas it was absent in the remaining case. All 3 cases showed diffuse immunohistochemical expression of GRM1, and <i>GRM1</i> rearrangement was confirmed with fluorescence in situ hybridization. CMF with limited or no chondromyxoid stroma is a rare variant that histologically overlaps with other giant cell-rich tumors. Recognition of this pattern is essential for appropriate clinical management, and the demonstration of <i>GRM1</i> rearrangement and overexpression provides strong support for this challenging diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chondromyxoid fibroma with limited or no chondromyxoid stroma: A clinicopathological study of 3 cases

  • 期刊论文

  • 发表日期：

    2026年7月29日

查看全文
  • Ken-Ichi Yoshida,
  • Toru Motoi,
  • Toru Wakamatsu,
  • Satoshi Takenaka,
  • Toshihide Hirai,
  • Koichiro Mori,
  • Eisuke Kobayashi,
  • Akihiko Yoshida

摘要

Chondromyxoid fibroma (CMF) is a rare benign bone tumor characterized by lobulated growth, chondromyxoid stroma, and GRM1 rearrangement. Here, we describe 3 cases of CMF with limited or no chondromyxoid stroma. The patients (2 males and 1 female) were 14–18 years old and had lesions in the tibial diaphysis, rib, and pubic bone. The tumors measured 24–60 mm, and were central in 2 cases and juxtacortical in 1 case. Treatment included curettage and resection, and the tumors did not recur for 2 to 8 years after surgery. Histologically, all 3 tumors comprised sheets of uniform, non-atypical, ovoid or short spindle cells interspersed with numerous osteoclast-like giant cells. Delicate pericellular eosinophilic matrix was focally deposited in all cases, which showed chicken-wire calcification in 2 cases. Osteoid deposition in a conglomerate pattern was observed in 2 cases. Aneurysmal bone cystic changes were present in all cases. Chondromyxoid stroma was present only in ~ 10% and < 5% of the tumor volume in 2 cases, whereas it was absent in the remaining case. All 3 cases showed diffuse immunohistochemical expression of GRM1, and GRM1 rearrangement was confirmed with fluorescence in situ hybridization. CMF with limited or no chondromyxoid stroma is a rare variant that histologically overlaps with other giant cell-rich tumors. Recognition of this pattern is essential for appropriate clinical management, and the demonstration of GRM1 rearrangement and overexpression provides strong support for this challenging diagnosis.